A true Innovation Hub
Our expertise spans a comprehensive spectrum of biologics, including plasmids, proteins, mRNA, viral vectors cell therapy, and an array of other advanced therapeutic entities. It is our relentless pursuit of excellence and innovation that led to our recognition in 2021 as a national Innovation Hub for advanced therapeutics and vaccines by the Swedish Government, a milestone that underscores our role in shaping the future of healthcare.
NorthX Biologics was created as an Innovation Hub to support advanced biologics and designed to move products forward in their pre-clinical, clinical and even commercial journey’s. Learn more about our sites, our people and what we do below.
Our sites
NorthX Matfors (Headquarters)
- 9,500m2 facility
- 2,500m2 purpose-built flexible clean rooms up to grade A/B
- Experts in microbial expression systems including proteins, plasmid DNA, mRNA, live bacterial therapeutics and cell therapy manufacturing
- Non-GMP and GMP production
- BSL2
- Aseptic Fill/Finish for clinical and commercial material
NorthX Stockholm
- 2,000m2 facility
- 500m2 purpose-built flexible clean rooms up to grade A/C
- Experts in mammalian development and manufacturing, virus, viral vectors and recombinant protein manufacturing
- Non-GMP and GMP production
- BSL2/BSL3/Polio
Our leadership
Janet Hoogstraate, PhD
Chief Executive Officer
As CEO of NorthX Biologics, Janet brings a vast amount of experience to the table. Most recently coming from a position as the managing director at Valneva, Janet has also worked in preclinical R&D at Astra Pain Control, as well at various leadership positions in drug discovery and development in neuroscience. She is also a trusted board member of Mireca Medicines GmbH, Alzecure Pharma AB and APL AB. Janet has a PhD in biopharmaceutical sciences from Leiden University in the Netherlands and an EMBA from Hult International School in London.
Maria Rynell
Chief Financial Officer
Maria joined NorthX Biologics in 2022 as CFO. She brings 20 years of experience in finance and controlling to the company, coming from positions as Finance Director, Group Controller and Head of Controlling at Recipharm AB and Bringwell AB. Maria has a master’s degree in accounting and finance from Stockholm University and is responsible for leading a team of multi-talented professionals working in finance, IT, HR and administration.
Peter Boman
Chief Operations Officer
Peter is the COO at NorthX Biologics, and as such responsible for our manufacturing facilities in Matfors. He holds a master’s degree in engineering, biotechnology, and business administration. Peter has worked in research and development with complex sample analytics, analytical development, and cell culture process development. He joined NorthX in 2013 and has since continuously improved his talented team, resulting in the production of a large number of biological drugs for clinical trials.
Helena Pettersson
Chief Production Officer
Helena is CPO at NorthX Biologics as well as Head of Upstream at our Stockholm site. She holds a master’s degree in chemical engineering, biotechnology from Mälardalens University. With former roles as scientist in process development at Pharmacia, CMC development at SOBI, and leadership in process development at Crucell, Helena brings more than 25 years of experience. She manages a highly skilled and experienced team, making sure we are on top of the advanced therapeutics sector.
Ola Tuvesson
Chief Technology Officer
As CTO, Ola is leading NorthX Biologic’s development and project organization, focusing on delivering technologies and strategies to ensure high-end services within bioprocessing and analytics. He has more than 20 years’ experience from the pharma and biotech industry, ranging from early development to commercial GMP manufacturing. Ola has worked in several fields, including ATMP products, vaccines, and other biologicals. He has the essential knowledge to take a product from early pre-clinical development into clinical trials and to the market.
Thomas Beck
Chief Quality Officer
Thomas joined NorthX Biologics in 2021 and brought with him an impressive amount of experience and knowledge of the industry. He has a master’s degree in chemical engineering from the Royal Institute of Technology (KTH) and studied pharmaceutical science at Uppsala University to be accredited as a Qualified Person. Thomas also holds a Certificate of Proficiency in pharmaceutical engineering from Leeds University. He has experience from all fields of the pharmaceutical industry, most recent as the Senior Vice President for Recipharm, responsible for global quality.
Eva-karin Gidlund, PhD, MBA
Chief Business Officer
Eva-karin joined NorthX Biologics in 2019 as Collaboration Development Manager and quickly advanced to Chief Business Officer (CBO). With a PhD in Medicine from Karolinska Institutet and an MBA, she bridges the gap between innovation, academia, and the pharmaceutical industry. Eva-Karin drives strategic partnerships and growth, focusing on cell and gene therapies. A dynamic leader and speaker, she has been featured at TEDxTalk and Bünsow Business. Her goal is to translate scientific breakthroughs into impactful industry solutions.
Magnus Gustafsson, PhD, MBA
Chief Commercial Officer
As an experienced leader, Magnus drives complex projects across multidisciplinary teams, focusing on customer happiness at the intersection of R&D and market strategy. He has over 20 years of experience negotiating global agreements, including NDAs, MSAs, and supply and license contracts. Magnus holds an MSc in Biochemical Engineering, an MBA, and a PhD in Medical Biochemistry and Biophysics. His previous roles include senior positions at 3PBiovian, Cytiva, and Cobra Biologics, where his responsibilities included all aspects of business development, marketing, project management, and corporate partnerships.
Our complete biologics manufacturing services
We can support your project from concept through to commercial manufacturing. Our speed and flexibility allow for rapid program design and execution to overcome development challenges.